• Verification code
  • Optimal Prices
    Buying products on this site guarantees the best price
  • Flexible Batches
    Flexible batch size to meet different needs of global customers
  • Prompt Delivery
    Warehouses in multiple cities to ensure timely delivery
  • Quality Assurance
    Strict process parameter control to ensure product quality
  • One-to-one Customization
    One-to-one custom synthesis for special structural needs

Bortezomib-[d8]

General Information
Catalog: BLP-002087
Molecular Formula: C19H17D8BN4O4
Molecular Weight: 392.29
Chemical Structure
Bortezomib-[d8]
Description Bortezomib-[d8], is the labelled analogue of Bortezomib. Bortezomib is an anti-cancer medication used to treat multiple myeloma and mantle cell lymphoma.
Synonyms Bortezomib D8
IUPAC Name [(1R)-3-methyl-1-[[2,3,3-trideuterio-3-(2,3,4,5,6-pentadeuteriophenyl)-2-(pyrazine-2-carbonylamino)propanoyl]amino]butyl]boronic acid
Related CAS 179324-69-7 (unlabelled)
Canonical SMILES B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
InChI InChI=1S/C19H25BN4O4/c1-13(2)10-17(20(27)28)24-18(25)15(11-14-6-4-3-5-7-14)23-19(26)16-12-21-8-9-22-16/h3-9,12-13,15,17,27-28H,10-11H2,1-2H3,(H,23,26)(H,24,25)/t15?,17-/m0/s1/i3D,4D,5D,6D,7D,11D2,15D
InChI Key GXJABQQUPOEUTA-CXLUSBQQSA-N
Melting Point 122-124°C
Purity > 98%
Density 1.214 g/cm3
Solubility Soluble in chloroform, dimethyl sulfoxide, ethanol, methanol
Appearance White to Pale Yellow Solid
Storage Store at -20°C, under inert atmosphere

Interested in our Service & Products?
Need detailed information?

USA
  • International:
  • US & Canada (Toll free):
  • Email:
  • Fax:
UK
  • Email:
Copyright © 2024 BOC Sciences. All Rights Reserved.
Inquiry Basket